Samsung Electronics Co. Ltd (BC94)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 3,976.00 |
|---|---|
| 52-week range | 1,575.00 – 6,055.00 |
| Return, 1 month / 3 months | −21.3% / −12.3% |
| Return, 1 year / 3 years | +138.1% / +227.8% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 65.6% |
| Worst drawdown (1 year) | -38.2% |
| Average daily value traded | 78.50M USD |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Samsung Electronics is a South Korean technology company based in Suwon. It designs and makes consumer electronics such as smartphones, televisions, monitors and home appliances, and it produces memory chips, displays and other semiconductor components. Its customers include everyday consumers who buy its devices and other manufacturers that use its components. The company serves markets around the world through its own brands and through sales to business customers.
On this site Samsung Electronics Co. Ltd appears as a stock on the London Exchange (UK), code BC94, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Samsung Electronics Co. Ltd (BC94) trades on the London Exchange in UK. It last closed at USD 3,976.00 on 22 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,930 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 138.1% and over the last three months it fell 12.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.7% | ||
| From 52-week high | -33.8% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.3% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | 202.4% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 65.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.2% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 78.50M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −21.3% |
| 3 months | −12.3% |
| 6 months | +6.3% |
| 1 year | +138.1% |
| 3 years | +227.8% |
| 5 years | +190.3% |
Signals
| 50-day / 200-day average | 4,726.95 / 4,129.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 217.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | USD 5.2679 |
| 30 Mar 2026 | USD 4.7936 |
| 29 Dec 2025 | USD 8.0842 |
| 29 Sep 2025 | USD 5.3308 |
| 27 Jun 2025 | USD 5.0915 |
| 28 Mar 2025 | USD 6.0099 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.